Abstract
Heat shock proteins (HSPs) are associated with a broad spectrum of peptides derived from the cells from which they are isolated. Vaccination with such HSP-peptide complexes elicits protective immunity against tumors or other cells used as the source of HSPs. These observations suggest that HSP-peptide complexes are suitable as vaccines against cancers and infectious diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 728-732 |
| Number of pages | 5 |
| Journal | Current Opinion in Immunology |
| Volume | 6 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1994 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
Cite this
Heat shock protein-peptide complexes in cancer immunotherapy. / Srivastava, Pramod K.; Udono, Heiichiro.
In: Current Opinion in Immunology, Vol. 6, No. 5, 1994, p. 728-732.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Heat shock protein-peptide complexes in cancer immunotherapy
AU - Srivastava, Pramod K.
AU - Udono, Heiichiro
PY - 1994
Y1 - 1994
N2 - Heat shock proteins (HSPs) are associated with a broad spectrum of peptides derived from the cells from which they are isolated. Vaccination with such HSP-peptide complexes elicits protective immunity against tumors or other cells used as the source of HSPs. These observations suggest that HSP-peptide complexes are suitable as vaccines against cancers and infectious diseases.
AB - Heat shock proteins (HSPs) are associated with a broad spectrum of peptides derived from the cells from which they are isolated. Vaccination with such HSP-peptide complexes elicits protective immunity against tumors or other cells used as the source of HSPs. These observations suggest that HSP-peptide complexes are suitable as vaccines against cancers and infectious diseases.
UR - http://www.scopus.com/inward/record.url?scp=0028114348&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028114348&partnerID=8YFLogxK
U2 - 10.1016/0952-7915(94)90076-0
DO - 10.1016/0952-7915(94)90076-0
M3 - Article
C2 - 7826528
AN - SCOPUS:0028114348
VL - 6
SP - 728
EP - 732
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
SN - 0952-7915
IS - 5
ER -